[Isolated elevation of troponin-T level after percutaneous coronary interventions: clinical significance]
Insights
Isolated elevation of troponin-T (Tn-T) after percutaneous coronary interventions (PCI) did not increase long-term mortality. However, patients with elevated Tn-T showed a trend toward more nonfatal myocardial infarctions (MI).
Area of Science:
- Cardiology
- Biomarkers
- Interventional Cardiology
Context:
- Percutaneous coronary interventions (PCI) are common for ischemic heart disease.
- Assessing the prognostic significance of post-PCI troponin-T (Tn-T) elevation is crucial.
- Creatine kinase MB fraction levels were normal, isolating Tn-T as the marker of interest.
Purpose:
- To investigate the relationship between isolated troponin-T elevation after elective PCI and remote patient outcomes.
- To determine if elevated Tn-T levels predict cardiac death or nonfatal myocardial infarction (MI) in the long term.
Summary:
- 124 patients with ischemic heart disease undergoing elective PCI were studied.
- Patients were grouped based on post-PCI troponin-T (Tn-T) levels (elevated vs. normal).
- No significant differences in in-hospital outcomes or 5-year survival were observed, though a trend towards more nonfatal MIs in the elevated Tn-T group was noted.
Impact:
- Isolated troponin-T elevation after PCI may not significantly impact long-term mortality.
- Further research is warranted to clarify the association between elevated Tn-T and nonfatal myocardial infarction risk post-PCI.
- Findings contribute to understanding the prognostic value of cardiac biomarkers after interventional procedures.
Abstract:
Relationship between isolated elevation of troponin-T (Tn-T) level after percutaneous coronary interventions (PCI) and remote outcomes was studied in 124 patients with ischemic heart disease with normal level of creatine kinase MB fraction after elective PCI. Blood samples for measurement of markers of myocardial necrosis were taken before, and in 8 and 24 hours after PCI. Patients were divided into 2 groups: without (n=58, group 1) and with (n=54, group 2) postprocedural elevation of Tn-T level above upper limit of normal ( more or equal 0.03 hg/ml). During follow-up we registered primary end points (cardiac deaths, nonfatal myocardial infarctions [MI]) and composite criterion comprising first occurrence of either of these outcomes. We also assessed 1, 2, 3, 4 and 5 year survival. There were no inhospital deaths and no significant differences between groups in rate of nonfatal MI (2 vs 0%) and occurrence of composite criterion (2 vs 0%). During long term follow-up Tn-T elevation also was not associated with increased number of deaths. However nonfatal MIs were more frequent and risk of death/MI higher in group 2 compared with group 1(6.5 vs 9.3%, p>0.05 and 15.5 vs 16.7%; p>0.05, respectively). Five year survival of patients with elevated Tn-T was not lower compared with patients of group 1.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests

